338 related articles for article (PubMed ID: 18996382)
41. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities.
Mintzer M; Curtis P; Resnick JC; Morrell D
Cancer; 1999 Jun; 87(3):113-7. PubMed ID: 10385441
[TBL] [Abstract][Full Text] [Related]
42. Early measles virus infection is associated with the development of inflammatory bowel disease.
Pardi DS; Tremaine WJ; Sandborn WJ; Loftus EV; Poland GA; Harmsen WS; Zinsmeister AR; Melton LJ
Am J Gastroenterol; 2000 Jun; 95(6):1480-5. PubMed ID: 10894583
[TBL] [Abstract][Full Text] [Related]
43. Suboptimal rates of cervical testing among women with inflammatory bowel disease.
Long MD; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2009 May; 7(5):549-53. PubMed ID: 18996498
[TBL] [Abstract][Full Text] [Related]
44. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
[TBL] [Abstract][Full Text] [Related]
45. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
46. Fetal and perinatal risk factors for inflammatory bowel disease.
Aspberg S; Dahlquist G; Kahan T; Källén B
Acta Paediatr; 2006 Aug; 95(8):1001-4. PubMed ID: 16882577
[TBL] [Abstract][Full Text] [Related]
47. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
48. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
García Rodríguez LA; Ruigómez A; Panés J
Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for opportunistic infections in patients with inflammatory bowel disease.
Toruner M; Loftus EV; Harmsen WS; Zinsmeister AR; Orenstein R; Sandborn WJ; Colombel JF; Egan LJ
Gastroenterology; 2008 Apr; 134(4):929-36. PubMed ID: 18294633
[TBL] [Abstract][Full Text] [Related]
50. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
Mitchell H; Hocking J; Saville M
Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
[TBL] [Abstract][Full Text] [Related]
51. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
Abdul MA; Shittu SO; Randawa JA; Shehu MS
Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
[TBL] [Abstract][Full Text] [Related]
52. [Smoking and ovulation inhibitor in inflammatory bowel diseases].
Katschinski B
Med Klin (Munich); 1993 Feb; 88 Suppl 1():5-8. PubMed ID: 8464399
[TBL] [Abstract][Full Text] [Related]
53. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease.
Kane S; Khatibi B; Reddy D
Am J Gastroenterol; 2008 Mar; 103(3):631-6. PubMed ID: 17941962
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
55. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey.
Longobardi T; Jacobs P; Wu L; Bernstein CN
Am J Gastroenterol; 2003 Apr; 98(4):844-9. PubMed ID: 12738466
[TBL] [Abstract][Full Text] [Related]
56. The evolving epidemiology of inflammatory bowel disease.
Shanahan F; Bernstein CN
Curr Opin Gastroenterol; 2009 Jul; 25(4):301-5. PubMed ID: 19349861
[TBL] [Abstract][Full Text] [Related]
57. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study.
Nørgård B; Puho E; Pedersen L; Czeizel AE; Sørensen HT
Am J Gastroenterol; 2003 Sep; 98(9):2006-10. PubMed ID: 14499779
[TBL] [Abstract][Full Text] [Related]
58. [Pharmacologic therapy of Crohn's disease and ulcerative colitis].
Banai J
Orv Hetil; 2000 May; 141(22):1171-7. PubMed ID: 10853345
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004.
Karolewska-Bochenek K; Lazowska-Przeorek I; Albrecht P; Grzybowska K; Ryzko J; Szamotulska K; Radzikowski A; Landowski P; Krzesiek E; Ignys I; Fyderek K; Czerwionka-Szaflarska M; Jarocka-Cyrta E
Digestion; 2009; 79(2):121-9. PubMed ID: 19321943
[TBL] [Abstract][Full Text] [Related]
60. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis.
Timmer A; Kemptner D; Bauer A; Takses A; Ott C; Fürst A
BMC Gastroenterol; 2008 Oct; 8():45. PubMed ID: 18834529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
